Peptide therapy for women's hormones: what the science says

What's this video probably claiming?

Based on the hashtags and creator context, this video is likely promoting peptide therapy, specifically compounds like CJC-1295, ipamorelin, or BPC-157, as tools for women's hormonal balance and metabolic health. The framing around a functional medicine NP and the phrase "feel like themselves from the inside out" signals a wellness-forward pitch. These types of videos typically position peptides as gentler, more natural alternatives to conventional hormone therapy, often suggesting benefits like improved energy, body composition, sleep quality, and mood. The presence of a master injector alongside a functional medicine practitioner suggests the practice is offering both injectable peptide protocols and aesthetic services, which is a common dual-revenue model in the medspa space. Expect claims that peptides support growth hormone, reduce inflammation, accelerate recovery, and improve skin quality, all wrapped in language that implies these outcomes are well-established rather than preliminary.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and the evidence quality varies wildly. CJC-1295 combined with ipamorelin does stimulate growth hormone release. Raun et al. (2004, Growth Hormone IGF Research) showed CJC-1295 increased mean growth hormone concentrations significantly in healthy adults, but most trials run 8-12 weeks with small sample sizes under 30 participants. BPC-157 has shown tissue repair effects in rat models, but as of 2024, zero randomized controlled trials in humans have been published. GHK-Cu has legitimate skin research behind it, with Pickart and Margolina (2018, Biomolecules) showing collagen synthesis stimulation in vitro, but topical versus injected delivery is a separate question entirely. MK-677 is an oral growth hormone secretagogue, not technically a peptide, and the Nass et al. (2008, Annals of Internal Medicine) trial found modest lean mass gains but also significant insulin resistance increases. The evidence base for peptides in women specifically is even thinner.

Where does the social media noise diverge from clinical reality?

The gap is significant. Functional medicine content tends to present peptides as personalized, data-driven interventions when the clinical reality is that most protocols are extrapolated from bodybuilding communities, not peer-reviewed women's health research. The framing of peptides as "hormone support" is particularly slippery. Growth hormone secretagogues like CJC-1295 do affect the GH-IGF-1 axis, but calling that hormonal balance for women implies it addresses estrogen, progesterone, or cortisol dysregulation, which it does not directly do. The FDA has not approved any of these peptides for the uses being implied here. In 2023, the FDA and several state boards issued warnings about compounded peptides, specifically BPC-157 and TB-500, citing lack of safety data. The medspa aesthetic pairing also blurs the line between medical treatment and cosmetic service in ways that can confuse patients about what they're actually consenting to.

What should you actually know?

If you're a woman considering peptide therapy from a medspa or functional medicine practice, there are practical questions worth asking before you agree to anything. First, ask which peptides are being proposed and request the specific evidence for your health concern, not general wellness claims. Second, understand that most compounded peptides exist in a regulatory gray zone. They are not FDA-approved drugs, and compounding quality control varies between pharmacies. Third, some peptides carry real risks: MK-677 can raise fasting glucose meaningfully, which matters if you have insulin resistance. IGF-1 elevation from growth hormone secretagogues is a theoretical concern in people with hormone-sensitive conditions. Fourth, the combination of aesthetic services and medical peptide therapy at the same appointment is not inherently wrong, but it warrants scrutiny about whose medical judgment is guiding your protocol. An NP can prescribe in most states, but verify your state's telehealth and medspa supervision requirements before proceeding.